Moyamoya Syndrome as an Unusual Presenting Manifestation of Systemic Lupus Erythematosus in a Young Woman

Oral contraceptive-related transverse sinus thrombosis as an initial manifestation of antiphospholipid syndrome in the absence of systemic lupus erythematosus

Hematologic manifestation of systemic lupus erythematosus

Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease. The most common hematologic finding is anemia, leukopenia, thrombocytopenia and secondary antiphospholipid syndrome with recurrent abortion and thrombosis. The autoimmune fibrosis of bone marrow is another manifestation of autoimmune disease especially SLE, that must be correctly differentiated from primary myelofibrosis.

PSEUDO TUMOR CEREBRI AS THE MAJOR MANIFESTATION OF SYSTEMIC LUPUS ER Y THEMATOSUS IN A CASE OF FEVER OF UNDE TERMINED ORIGIN

Systemic lupus erythematosus (SLE) is less likely to present as fever of undetermined origin today. This is due to the widespread use of immunologic tests which permit early diagnosis. It is not surprising therefore that only atypical cases of SLE present as FUa. Although uncommon, pseudotumor cerebri has been recognized as either a presenting manifestation or a complication of SLE. This c...

Thrombolytic Therapy for Cerebral Vein Thrombosis in Antiphospholipid Syndrome Secondary to Systemic Lupus Erythematosus

A 20-year-old woman was admitted to a Gynecology Hospital in her 6th month of pregnancy for high blood pressure and tonic-clonic seizure. Primary diagnosis was eclampsia, and for that reason she underwent cesarean section. She also had headache on frontal and parietal areas without nausea or vomiting. There was not a focal neurological sign. Rheumatology consultation was requested. Systemic lup...

Moyamoya syndrome occurred in a girl with an inactive systemic lupus erythematosus

We report the case of a 17-year-old Korean girl with systemic lupus erythematosus (SLE) who presented with sudden weakness of the right-sided extremities and dysarthria. Oral prednisolone was being taken to control SLE. Results of clinical and laboratory examinations did not show any evidence of antiphospholipid syndrome or thromboembolic disease nor SLE activity. Cerebral angiography showed st...